Biomerica Stock to Reverse Split on Monday, April 21st (NASDAQ:BMRA)

Shares of Biomerica, Inc. (NASDAQ:BMRA) are scheduled to reverse split before the market opens on Monday, April 21st. The 1-8 reverse split was announced on Wednesday, April 16th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, April 18th.

Biomerica Stock Performance

BMRA opened at $0.42 on Thursday. The stock’s 50 day moving average price is $0.66 and its 200-day moving average price is $0.47. Biomerica has a one year low of $0.24 and a one year high of $1.27. The stock has a market cap of $7.70 million, a price-to-earnings ratio of -1.24 and a beta of 0.37.

Biomerica (NASDAQ:BMRA) last released its earnings results on Monday, April 14th. The company reported ($0.06) earnings per share for the quarter. The business had revenue of $1.12 million during the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

Institutional Trading of Biomerica

An institutional investor recently raised its position in Biomerica stock. Granahan Investment Management LLC lifted its position in shares of Biomerica, Inc. (NASDAQ:BMRA) by 24.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 658,767 shares of the company’s stock after purchasing an additional 131,306 shares during the quarter. Granahan Investment Management LLC owned 3.59% of Biomerica worth $198,000 as of its most recent SEC filing. Institutional investors own 22.28% of the company’s stock.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.